• Capturing Pre-Commercial-$tage Value

    Welcome to Life Science Deal Flow. Our aim here is to hold my mouse to the fire by documenting the winners (and losers) of my life science trades and strategies. The focus is on a unique opportunities presented by pre-commercial stage life science entities. Don't forget to visit and subscribe to my other site, a FREE Venture Capital and competitive intelligence dBase, OnBioVC.
  • SEARCH the Life Science Deal Flow ARCHIVE

  • business strategy life science

An agreement was reached with Longmont-based Chemizon and the Korean Research Institute of Bioscience and Biotechnology (KRIBB) to spin out a new biotech company designed to commercialize KRIBB’s intellectual property assets with an emphasis on technologies targeting the discovery of drugs that address unmet medical needs. The deal is led by Chemizon-Oakwood Bioventures private equity [...]

If Chemizon had not been on your radar well consider yourself now in the loop…if you have been looking for a local drug discovery platform then look no further than Longmont’s Chemizon. Back in 2006 Tony Piscopio, Ph.D. who co-founded Array Biopharma (NASDAQ: ARRY) departed to found Chemizon. Chemizon is a provider of drug discovery [...]

  

to top of page...


 
  • The Latest LSDF Activity

    May 2012
    M T W T F S S
    « Oct    
     123456
    78910111213
    14151617181920
    21222324252627
    28293031  
  • Search the LSDF Archive

  • Your Advert Can Go Here!

    Find out how, email: arubenstein@rnaventures.com